Research and analysis

ACMD Naloxone Review

The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.

• From: Advisory Council on the Misuse of Drugs
• Published: 17 June 2022
• Last updated: 26 September 2023 — See all updates

Documents

ACMD review of the UK naloxone implementation (accessible)

HTML

ACMD review of the UK naloxone implementation

PDF, 798 KB, 89 pages

Government reponse to UK naloxone implementation report

HTML

Details

The Advisory Council of the Misuse of Drugs (ACMD) has reviewed the evidence on the provision and availability of naloxone, a medicine which can temporarily reverse the effects of opioids and is used as an emergency treatment for people who overdose on these drugs. The findings of this review, and recommendations to optimise the use of naloxone are presented in this report.

The government response to this report was published on 25 September 2023.

Published 17 June 2022
Last updated 26 September 2023 + show all updates

1. 26 September 2023

   Government response added to page.

2. 17 June 2022

   First published.